[11] Structure [edit] The GLP-1 receptor is a transmembrane protein composed of seven alpha-helical transmembrane domains (TM1-TM7), an extracellular N-terminus, and an intracellular C-terminus
Ingelfinger, MD, from @TuftsMedSchool and the Maine Medical Center Institute for Research: nejm.org/doi/full/10.10 - Randomized, placebo-controlled trials of the glucagon-like peptide-1 (GLP-1) receptor agonists have provided strong evidence to support their use in fact, they have presaged a mini-revolution in how type 2 diabetes is managed
Amber-coloured glass vials are commonly used to shield peptides from light, and proper sealing ensures that humidity cannot easily penetrate
Monitoring your progress during a stall When the scale stops being a useful metric, you need other tools
10.1016/j.tox.2022.153340 84 National Research Council (2007)
Monitoring and Follow-Up Considerations Providers typically monitor response over time using symptoms, labs when appropriate, and safety assessments